Sign In
Buy ACST
$3.37
+0 (+0%)
At Close: Jan 24, 2025
Analysts Are Bullish on These Healthcare Stocks: Atricure (ATRC), Medtronic (MDT)
11:04am, Wednesday, 19'th Feb 2020
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Atricure (ATRC), Medtronic (MDT) and Acasti Pharma (ACST)
Analysts Are Bullish on These Healthcare Stocks: Atricure (ATRC), Medtronic (MDT)
11:03am, Wednesday, 19'th Feb 2020
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Atricure (
ATRC
–
Research Report
), Medtronic (
MDT
–
Research Report
) and Acasti Pharma (
ACST
�
10 Biggest Price Target Changes For Tuesday
01:35pm, Tuesday, 18'th Feb 2020
Wells Fargo lowered PVH Corp (NYSE: PVH) price target from $115 to $110. PVH closed at $89.37 on Friday.
Bernstein raised the price target for Tesla Inc (NASDAQ: TSLA) from $...
H.C. Wainwright Maintains Buy on Acasti Pharma, Lowers Price Target to $3
12:00am, Tuesday, 18'th Feb 2020Risks Remain, but Amarin Stock Is a Buy at Today’s Prices
04:41pm, Friday, 14'th Feb 2020
Is there more upside in the cards for Amarin (NASDAQ:AMRN) stock? Shares soared late last year on news of the company's flagship Vascepa treatment receiving an expanded label. But after climbing from
Acasti Pharma Provides Business Update for the Third Quarter of Fiscal 2020
01:00pm, Friday, 14'th Feb 2020
LAVAL, Québec, Feb. 14, 2020 -- Acasti Pharma Inc. (“Acasti or the “Company”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research,.
Acasti Pharma Schedules Third Quarter Fiscal 2020 and Business Update Conference Call
02:00pm, Thursday, 13'th Feb 2020
Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug
Acasti Pharma Schedules Third Quarter Fiscal —…—… and Business Update Conference Call
12:00am, Thursday, 13'th Feb 20203 Beaten-Down Biotech Stocks With +50% Upside Potential
04:27pm, Tuesday, 11'th Feb 2020
After a stock endures a beating from the public market, it can be tempting to abandon ship. As any seasoned investor knows, if a stock has fallen from grace and is trading at lower levels, there could
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 10) AbbVie Inc (NYSE: ABBV ) Allergan plc (NYSE: AGN )
80 Biggest Movers From Yesterday
09:44am, Tuesday, 11'th Feb 2020
Gainers
Taubman Centers, Inc. (NYSE: TCO) shares jumped 53.2% to close at $53.12 on Monday. Simon Property Group, Inc. (NYSE: SPG) said Monday it plans to purchase an 80%...
Acasti Pharma Provides Update on TRILOGY 1 and TRILOGY 2 Phase 3 Trials of CaPre
12:00pm, Monday, 10'th Feb 2020
Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug
Mid-Afternoon Market Update: Dow Rises 70 Points; vTv Therapeutics Shares Jump
12:00am, Monday, 10'th Feb 20206 Biotechnology Stocks Moving In Wednesday's Pre-Market Session
12:42pm, Wednesday, 05'th Feb 2020
Gainers
• Moleculin Biotech, Inc. (NASDAQ:MBRX) stock rose 35.2% to $1.19 during Wednesday's pre-market session.
• Arbutus Biopharma, Inc. (NASDAQ:ABUS) shares rose...
